Cancer, Bladder Withdrawn Phase 3 Trials for Sirolimus (DB00877)

Also known as: Bladder Cancers / Bladder Cancer / Malignant neoplasm of urinary bladder NOS / Bladder neoplasms malignant / Malignant neoplasm of bladder / Urinary Bladder Cancer / Malignant neoplasm of bladder, part unspecified / Bladder cancer NOS / Ca bladder

DBCOND0092003 (Cancer, Bladder)Withdrawn3 IdentifierTitlePurposeDrugs
NCT03298958Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder CancerTreatment